Related Experiment Video
Updated: May 11, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
New molecular insights into osteosarcoma targeted therapy
1Department of Bone and Soft Tissue Tumors, Tianjin Medical University, Cancer Hospital and Institute, Tianjin, China. yangjilong@tjmuch.com
Current Opinion in Oncology
|May 14, 2013
Summary
Recent studies reveal new molecular targets for osteosarcoma, focusing on genetic aberrations and pathways involved in tumor growth, invasion, and drug resistance. These findings offer promising therapeutic avenues for osteosarcoma patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma pathogenesis involves complex genetic aberrations.
- Understanding these aberrations is crucial for developing targeted therapies.
Purpose of the Study:
- To review recent translational studies in osteosarcoma.
- To identify novel molecular therapeutic targets for osteosarcoma.
Main Methods:
- Review of translational research in osteosarcoma.
- Analysis of genetic aberrations and molecular pathways.
Main Results:
- Identified genetic aberrations in VEGF, mTOR, Wnt pathway, p53, Rb, WWOX, APEX1, c-myc, and others.
- Highlighted therapeutic targets including integrin, ezrin, statin, NOTCH/HES1, MMPs, m-calpain, Src, and various proteins involved in proliferation, apoptosis, growth, angiogenesis, and drug sensitivity.
- Noted microRNAs like miR-215 as potential targets.
Conclusions:
- Translational studies have successfully identified new molecular targets for osteosarcoma.
- These targets offer potential for novel therapeutic strategies against osteosarcoma.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...